跳至主要内容
临床试验/CTRI/2024/01/061489
CTRI/2024/01/061489尚未招募4 期

Randomized controlled trial to compare the efficacy and safety of Polmacoxib with standard of care in the management of Osteoarthritis in South India - NI

Dr Elavarasi R0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with newly diagnosed or Treatment naive Primary Osteoarthritis based on ACR clinical classification criteria.
  • 2. WOMAC OA index score of 49 to 79 baseline
  • 3. Patients willing to provide informed written consent.
  • 4. Subjects capable and willing to comply with study procedures

排除标准

  • 1)Patients with secondary osteoarthritis.
  • 2)Patients with Cardiovascular disease, uncontrolled hypertension, gastrointestinal bleeding and chronic illness of liver, kidney.
  • 3)Patients using any other analgesic or Acetaminophen except study medication.
  • 4)Use of Anticoagulants within 2 weeks of screening.
  • 5)Use of Corticosteroids, Herbal medicines, Glucosamines, Chondroitin sulphates.
  • 6)Hypersensitivity to NSAIDs.

研究者

发起方
Dr Elavarasi R

相似试验